Ifenec

Econazole Nitrate, the active ingredient in Ifenec, is an imidazole antifungal presented as a vaginal formulation for local use. It acts against Candida species that cause vaginal yeast infections, providing relief from itching, burning, and abnormal discharge in adult women.

GNH USA supplies Ifenec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution in multiple regions.

Ifenec is used to treat fungal infections of the vaginal tract, specifically targeting Candida species.

Vaginal candidiasis: reduces signs and symptoms of yeast infection, including itching, burning and abnormal discharge. Recurrent vaginal candidiasis: may be used as a maintenance regimen to help prevent recurrence when prescribed by a healthcare professional.

Adverse reactions are generally localized to the site of application and may vary in severity.

Common Side Effects: - Vaginal irritation or burning sensation - Itching or mild pruritus in the genital area - Unusual vaginal discharge or spotting - Mild abdominal discomfort or cramping - Dryness of the vaginal mucosa - Temporary redness of surrounding skin

Serious or Rare Side Effects: - Allergic reaction with swelling, hives or difficulty breathing - Severe skin rash or Stevens‑Johnson‑like eruption - Significant liver enzyme elevation (rare with systemic absorption) - Persistent ulceration or severe inflammation of vaginal tissue - Unexplained fever or systemic signs of infection

Before using Ifenec, consider the following safety measures. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss potential risks with a clinician; the drug may be excreted in breast milk. - Known hypersensitivity: avoid if you have a documented allergy to econazole or other imidazoles. - Concurrent vaginal products: do not use douches, spermicides or other intravaginal medications simultaneously. - Underlying conditions: uncontrolled diabetes or immunosuppression may affect treatment response. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Potential drug interactions should be reviewed with a healthcare provider.

Major Interactions (Avoid): - Systemic azole antifungals (e.g., fluconazole, ketoconazole): increased risk of systemic toxicity. - Topical irritants (e.g., harsh soaps, antiseptic gels): may exacerbate local irritation.

Moderate Interactions (Monitor Closely): - Antibiotics that alter vaginal flora: could reduce efficacy of the antifungal. - Hormonal contraceptives: no direct interaction, but monitor for any unexpected vaginal symptoms. - Other intravaginal medications: may cause additive irritation; use sequentially if needed.